Paola Suatoni Unit of Thoracic Surgery Fondazione IRCCS Istituto Nazionale dei Tumori Biography Publications Institution JoVE Articles Paola Suatoni has not added a biography. If you are Paola Suatoni and would like to personalize this page please email our Author Liaison for assistance. Publications Baseline and Postoperative C-reactive Protein Levels Predict Mortality in Operable Lung Cancer European Journal of Cancer (Oxford, England : 1990). Jul, 2017 | Pubmed ID: 28472743 Inflammatory Status and Lung Function Predict Mortality in Lung Cancer Screening Participants European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP). Mar, 2017 | Pubmed ID: 28333763 Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Jun, 2017 | Pubmed ID: 28302568 C-reactive Protein Level Predicts Mortality in COPD: a Systematic Review and Meta-analysis European Respiratory Review : an Official Journal of the European Respiratory Society. Jan, 2017 | Pubmed ID: 28143876 Baseline C-reactive Protein Level Predicts Survival of Early-stage Lung Cancer: Evidence from a Systematic Review and Meta-analysis Tumori. Oct, 2016 | Pubmed ID: 27292573 Novel Method to Detect MicroRNAs Using Chip-based QuantStudio 3D Digital PCR BMC Genomics. Oct, 2015 | Pubmed ID: 26493562 Circulating MicroRNA Signature As Liquid-biopsy to Monitor Lung Cancer in Low-dose Computed Tomography Screening Oncotarget. Oct, 2015 | Pubmed ID: 26451608 Recent Advances of MicroRNA-based Molecular Diagnostics to Reduce False-positive Lung Cancer Imaging Expert Review of Molecular Diagnostics. Jun, 2015 | Pubmed ID: 25924864 Assessment of Circulating MicroRNAs in Plasma of Lung Cancer Patients Molecules (Basel, Switzerland). Mar, 2014 | Pubmed ID: 24619302 Clinical Utility of a Plasma-based MiRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: a Correlative MILD Trial Study Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2014 | Pubmed ID: 24419137 MikroRNA baserat Liquid Biopsy: Upplevelsen av den Plasma miRNA signatur klassificerare (MSC) för Lung Cancer Screening Mavis Mensah*1, Cristina Borzi*1, Carla Verri1, Paola Suatoni2, Davide Conte1, Ugo Pastorino2, Fortunato Orazio1, Gabriella Sozzi1, Mattia Boeri1 1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 2Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori JoVE 56326 Cancer Research
MikroRNA baserat Liquid Biopsy: Upplevelsen av den Plasma miRNA signatur klassificerare (MSC) för Lung Cancer Screening Mavis Mensah*1, Cristina Borzi*1, Carla Verri1, Paola Suatoni2, Davide Conte1, Ugo Pastorino2, Fortunato Orazio1, Gabriella Sozzi1, Mattia Boeri1 1Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 2Unit of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori JoVE 56326 Cancer Research